视网膜基因治疗改善无脉络膜症患者视力
该研究设计腺相关病毒载体表达REP1,通过视网膜下注射治疗14例无脉络膜症患者,主要终点为术后2年治疗眼与未手术对侧眼的视力变化。结果显示治疗眼视力改善优于对照眼(中位字母增益4.5 vs 1.5字母损失,P=0.04),6只治疗眼视力增益超过一行(>5字母)。提示视网膜基因治疗可维持并改善以晚期患者为主的队列视力。
要点
- 视网膜下注射AAV载体表达REP1治疗无脉络膜症,2年时治疗眼视力改善优于未治疗眼。
- 14只治疗眼中6只视力增益超过5字母(>1行),中位增益4.5字母。
- 2例患者出现并发症,但总体治疗眼视力仍优于对照眼。
核心结论
- 视网膜基因治疗可维持并改善以晚期无脉络膜症患者为主的视力,治疗眼优于未手术对侧眼。
研究设计与样本
- 基因治疗临床试验:设计腺相关病毒载体表达REP1,对14例无脉络膜症患者行视网膜下注射。
- 主要终点为术后2年治疗眼与未手术对侧眼的视力变化比较。
主要发现
- 治疗眼较对照眼视力改善:中位4.5字母增益 vs 1.5字母损失,P=0.04。
- 6只治疗眼视力增益超过一行(>5字母)。
- 2例患者出现并发症。
关键数值与推荐
- 主要终点:术后2年治疗眼与未手术对侧眼的视力变化。
- 视力变化中位值:治疗眼4.5字母增益,对照眼1.5字母损失,P=0.04。
- 6只治疗眼视力增益>5字母。
临床怎么用
- 视网膜下注射AAV载体表达REP1可能成为无脉络膜症等遗传性视网膜变性的治疗选择。
- 需关注视网膜下注射相关并发症,并在临床试验框架下评估长期视力获益。
局限性
- 样本量较小(14例),需更大规模研究验证。
- 2例患者出现并发症,提示手术安全性需进一步评估。
- 以晚期患者为主,结果外推至早期患者需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Retinal gene therapy is increasingly recognized as a novel molecular intervention that has huge potential in treating common causes of blindness, the majority of which have a genetic aetiology1-5. Choroideremia is a chronic X-linked retinal degeneration that was first described in 18726. It leads to progressive blindness due to deficiency of Rab-escort protein 1 (REP1). We designed an adeno-associated viral vector to express REP1 and assessed it in a gene therapy clinical trial by subretinal injection in 14 patients with choroideremia. The primary endpoint was vision change in treated eyes 2 years after surgery compared to unoperated fellow eyes. Despite complications in two patients, visual acuity improved in the 14 treated eyes over controls (median 4.5 letter gain, versus 1.5 letter loss, P = 0.04), with 6 treated eyes gaining more than one line of vision (>5 letters). The results suggest that retinal gene therapy can sustain and improve visual acuity in a cohort of predominantly late-stage choroideremia patients in whom rapid visual acuity loss would ordinarily be predicted.
引用
- Xue K, Jolly JK, Barnard AR, et al. Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia. Nat Med. 2018. PMID: 30297895. doi:10.1038/s41591-018-0185-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。